Search the PBPK Model Repository

Quickly find freely available drug and population models in our PBPK model repository.

The models provided have been collated from published examples which authors have shared in our Published Model Collection or developed as part of various global health projects in our Global Health Collection. This search facility searches both model collections simultaneously.

To contribute published user compound and/or population files, upload your files here: Upload Model Files

Searching Tips

You can use a * character as a wildcard at the end of a alphanumeric search term. The search term must start with at least one character before the wildcard. E.g., Rifam* will get you “Rifampicin” and “Rifampin”.
You can also use a * character as a wildcard in the middle of a alphanumeric search term. The search term must still start with at least one character before the wildcard. E.g., Rif*in will also get you “Rifampicin” and “Rifampin” .
You can also use a * character as a wildcard at the start of a alphanumeric search term. However you must use forward slashes to delimit the search term and use a point before the wildcard. E.g., /.*picin/ will only get you “Rifampicin”.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Found 112 Matches

Osimertinib_V14R1_AstraZeneca_20190717

Model Files Publication

Compound file from publication: Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug Label. Pilla Reddy V, Walker M, Sharma P, Ballard P, Vishwanathan K (2018). CPT Pharmacometrics Systems Pharmacolology. doi: 10.1002/psp4.12289.

Search Score: 1

Propofol_RES_V18R1_Simcyp_20190529

Model Files Publication

Simcyp developed propofol compound file. Compound summary included. This was developed as a research file and its current status and limitations are outlined in the summary document.

Search Score: 1

Tizanidine_RES_V18R1_Simcyp_20190809

Model Files Publication

Simcyp developed tizanidine compound file. Compound summary included. This was developed as a research file and its current status and limitations are outlined in summary document.

Search Score: 1

Chlorpromazine

Model Files Publication

Brand Name(s) include: Thorazine, Largactil, Ormazine

Indication: Schizophrenia, manic-depression

Drug Class: Conventional anitpsychotic

Date Updated: March 2024

The model at-a-glance

Absorption Model	First-Order, fa and ka predicted by Caco-2 data
Volume of Distribution	Minimal (optimized to IV data)
Route of Elimination	fm_CYP3A4= 80, fm_CYP2D6 = 20
Perpetrator DDI	Inhibition of CYP2D6
Validation	Model performance was verified in healthy volunteers and psychiatric patients. Two clinical studies with IV administration (7 to 10 mg) and ten clinical studies with oral administration (25 to 200 mg) were used for model verification. Simulations for eight of eleven clinical studies with a reported AUC were within 2-fold of the observed value. The fm_CYP1A2was verified through simulations of chlorpromazine in smokers and non-smokers. The fm_CYP2D6was verified through simulations of chlorpromazine coadministered with and without quinidine.
Limitations	Model was developed using 10 mg IV and 100 mg PO. Use of 7-10 mg IV dosing and oral doses of 100-200 mg were verified, but predictions of oral doses <100 mg PO are overestimated. Model does not include P-gp efflux. Model is not verified for use in perpetrator DDI simulations with CYP2D6 substrates.

Search Score: 1

Search the PBPK Model Repository

Searching Tips

Osimertinib_V14R1_AstraZeneca_20190717

Propofol_RES_V18R1_Simcyp_20190529

Tizanidine_RES_V18R1_Simcyp_20190809

Chlorpromazine

The model at-a-glance

Your Privacy